Precocious puberty: Growth and genetics

Hormone Research

Volumn 64, Issue SUPPL. 2, 2005, Pages 56-61

  Phillip, Moshe ^a,b   Lazar, Liora ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Epiphyseal growth plate; Genetics; Precocious puberty; Puberty

Indexed keywords

ALLELE; AUTOSOMAL DOMINANT INHERITANCE; COHORT ANALYSIS; CONFERENCE PAPER; DEVELOPMENTAL GENETICS; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HEREDITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IDIOPATHIC DISEASE; PRECOCIOUS PUBERTY; PREVALENCE; PRIORITY JOURNAL; SEGREGATION ANALYSIS; SEX DIFFERENCE; SEXUAL MATURATION;

ADOLESCENT; CHILD; FEMALE; GROWTH PLATE; HUMAN GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PUBERTY, PRECOCIOUS;

EID: 27944478274     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087760     Document Type: Conference Paper

References (53)

1. Grumbach MM, Styne DM: Puberty: Ontogeny, neuroendocrinology, physiology and disorders; in Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds): Williams' Textbook of Endocrinology, ed 9. Philadelphia, Pa., WB Saunders, 1998, pp 1509-1625.
2. Parent AS, Teilmann G, Juul A, Skakkebæk NE, Toppari J, Bourguignon JP: The timing of normal puberty and the age limits of sexual precocity: Variations around the world, secular trends, and changes after migration. Endocr Rev 2003;24:668-693.
3. Palmert MR, Boepple PA: Variation in the timing of puberty: Clinical spectrum and genetic investigation. J Clin Endocrinol Metab 2001;86:2364-2368.
4. Garn SM, Baily SM: Genetic and maturational processes; in Falkner F, Tanner JM (eds): Human Growth 1: Principles and Prenatal Growth. New York, Plenum Press, 1978, pp 307-330.
5. Sedlmeyer IL, Hirschhorn JN, Palmert MR: Pedigree analysis of constitutional delay of growth and maturation: Determination of familial aggregation and inheritance patterns. J Clin Endocrinol Metab 2002;87:5581-5586.
6. van den Akker OB, Stein GS, Neale MC, Murray RM: Genetic and environmental variation in menstrual cycles: Histories of two British twin samples. Acta Genet Med Gemellol 1987;36:541-548.
7. Fischbein S: Intra-pair similarity in physical growth of monozygotic and of dizygotic twins during puberty. Ann Hum Biol 1977;4:417-430.
8. Kaprio J, Rimpela A, Winter T, Viken RJ, Rimpela M, Rose RJ: Common genetic influences on BMI and age at menarche. Hum Biol 1995;67:739-753.
9. Van Wieringen JC: Secular growth changes; in Falkner F, Tanner JM (eds): Human Growth 1: Principles and Prenatal Growth. New York, Plenum Press, 1978, pp 445-473.
10. Wyshak G, Frish RE: Evidence for a secular trend in age of menarche. N Engl J Med 1982;306:1033-1035.
11. Proos LA, Hofvander Y, Tuvemo T: Menarcheal age and growth pattern of Indian girls adopted in Sweden. I. Menarcheal age. Acta Pædiatr Scand 1991;80:852-858.
12. Virdis R, Street ME, Zampolli M, Radetti G, Pezzini B, Benelli M, Ghizzoni L, Volta C: Precocious puberty in girls adopted from developing countries. Arch Dis Child 1998;78:152-154.
13. Bridges NA, Christopher JA, Hindmarsh PC, Brook CGD: Sexual precocity: sex incidence and etiology. Arch Dis Child 1994;70:116-118.
14. Crowly WF, Comite F, Vale W, Rivier J, Loriaux DL, Cutler GB Jr: Therapeutic use of pituitary desensitization with long-acting LHRH agonist: A potential new treatment of precocious puberty. J Clin Endocrinol Metab 1981;52:370-372.
15. Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwe C: Final height in central precocious puberty after long term treatment with a slow-release GnRH agonist. Arch Dis Child 1996;75:292-297.
16. Galluzzi F, Salti R, Bindi G, Pasquini E, La Cauza C: Adult height comparison between boys and girls with precocious puberty after long-term gonadotropin-releasing hormone analogue therapy. Acta Pædiatr 1998;87:521-527.
17. Heger S, Partsch CJ, Sippell WG: Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: Adult height, body proportions body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999;84:4583-4590.
18. Bouvattier C, Coste J, Rodrigue D, Teinturier C, Carel JC, Chaussain JL, Bougnères PF: Lack of effect of GnRH agonist on final height in girls with advanced puberty: A randomized long term pilot study. J Clin Endocrinol Metab 1999;84:3575-3578.
19. Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R: Sexual precocity in boys: accelerated versus slowly progressive puberty, gonadotropin-suppressive therapy and final height. J Clin Endocrinol Metab 2001;86:4127-4132.
20. Lazar L, Kauli R, Pertzelan A, Phillip M: Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab 2002;87:2090-2094.
21. Kletter GB, Kelch RP: Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 1994;79:331-334.
22. Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, Chaussain JL: Final height after long term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French Study Group of Decapeptyl in Precocious Puberty. J Clin Endocrinol Metab 1999;84:1973-1978.
23. Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GB Jr: Increased final height in precocious puberty after long-term treatment with LHRH agonists: The National Institutes of Health experience. J Clin Endocrinol Metab 2001;86:4711-4716.
24. Mauras N, Rogol AD, Veldhuis JD: Increased hGH production rate after low-dose estrogen therapy in prepubertal girls with Turner's syndrome. Pediatr Res 1990;28:626-630.
25. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO: Effects of age and sex on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51-58.
26. Veldhuis JD, Metzger DL, Martha PM Jr, Mauras N, Kerrigan JR, Keenan B, Rogol AD, Pincus SM: Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid replacement. J Clin Endocrinol Metab 1997;82:3414-3420.
27. Luna A, Wilson D, Wibbelsman C, Brown RC, Nagashima RJ, Hintz RL, Rosenfeld RG: Somatomedins in adolescence: A cross sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels. J Clin Endocrinol Metab 1983;57:268-271.
28. Rosenfield R, Furlanetto R, Bock D: Relationship of somatomedin-C concentrations to pubertal changes. J Pediatr 1983;103:723-728.
29. Oz OK, Millsaps R, Welch R, Birch J, Zerwekh JE: Expression of aromatase in the human growth plate. J Mol Endocrinol 2001;27:249-253.
30. Smith EP, Boyd J, Frank GR, Takahashi T, Cohen RM, Specker B, William TC, Lubahn DB, Korach K: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056-1061.
31. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K: Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80:3689-3698.
32. Weise M, De-Levi S, Barnes KM, Gafni RI, Abad V, Baron J: Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci USA 2001;98:6871-6876.
33. Eshet R, Maor G, Ben-Ari T, Ben Eliezer M, Gat-Yablonski G, Phillip M: The aromatase inhibitor letrozole increases epiphyseal growth plate height and tibial length in peripubertal male mice. J Endocrinol 2004;182:165-172.
34. Maor G, Segev Y, Phillip M: Testosterone stimulates insulin-like growth factor-I and insulin-like growth factor-I-receptor gene expression in the mandibular condyle - a model of endochondral ossification. Endocrinology 1999;140:1901-1910.
35. Phillip M, Maor G, Assa S, Silbergeld A, Segev Y: Testosterone stimulates growth of tibial epiphyseal growth plate and insulin-like growth factor-I-receptor abundance and growth in hypophysectomized and castrated rats. Endocrine 2001;16:1-6.
36. Clayton PE, Gill MS, Hall CM, Tillmann V, Whatmore AJ, Price DA: Serum leptin through childhood and adolescence. Clin Endocrinol (Oxf) 1997;46:727-733.
37. Maor G, Rochberger M, Segev Y, Phillip M: Leptin acts as a growth factor on the chondrocytes of skeletal growth center. J Bone Miner Res 2002;17:1034-1043.
38. Weise M, Flor A, Barnes KM, Cutler GB Jr, Baron J: Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty. J Clin Endocrinol Metab 2004;89:103-107.
39. Ruvalcaba RHA: Isosexual precocious puberty. Am J Dis Child 1985;139:1179-1180.
40. Rangasami JJ, Grant DB: Familial precocious puberty in girls. J R Soc Med 1992;85:497-498.
41. Fraise SD, Brenner PF: Familial precocious puberty affecting both sexes. Am J Dis Child 1982;136:560-561.
42. Hopwood NJ, Kelch RP, Helder LJ: Familial precocious puberty in a brother and sister. Am J Dis Child 1981;135:78-79.
43. Rohn R, Rousonelos G: Familial sexual precocity. Am J Dis Child 1986;140:741-742.
44. de Vries L, Kauschansky A, Shohat M, Phillip M: Familial central precocious puberty suggests autosomal dominant inheritance. J Clin Endocrinol Metab 2004;89:1794-1800.
45. Beranova M, Oliveira LM, Bedecarrats GY, Schipani E, Vallejo M, Ammini AC, Quintos JB, Hall JE, Martin KA, Hayes FJ, Pitteloud N, Kaiser UB, Crowley WF Jr, Seminara SB: Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2001;86:1580-1588.
46. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA, Colledge WH: The GPR54 gene as a regulator of puberty. N Engl J Med 2003;349:1614-1627.
47. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E: Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 2003;100:10972-10976.
48. Phillip M, Arbelle JE, Segev Y, Parvari R: Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N Engl J Med 1998;338:1729-1732.
49. Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF, Jameson JL: Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. N Engl J Med 1992;326:179-183.
50. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD: A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213-215.
51. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougnères P, Lebouc Y, Froguel P, Guy-Grand B: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
52. Shahab M, Mastronardi C, Seminara SB, Crowley WF, Ojeda SR, Plant TM: Increased hypothalamic GPR54 signaling: A potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci USA 2005;102:2129-2134.
53. Matkovic V, Ilich JZ, Skugor M, Badenhop NE, Goel P, Clairmont A, Klisovic D, Nahhas RW, Landoll JD: Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab 1997;82:3239-3245.